How the digitalization of pharmacy is transforming patient care.
Digital transformation in the healthcare industry has tremendous potential to change the way we approach patient care and to enhance the overall quality of care. This shift is particularly important in pharmacy, which is poised for digital innovation but is far-less advanced compared to other industries due to perceived barriers to adoption. Even in today’s digital era, many pharmacists still rely on handwritten prescriptions to provide patients with the medications they need.
Electronic prescribing, or e-prescribing, is one emerging innovation with great potential to mitigate the issues associated with hard copy prescriptions, such as forgery and fraud; illegible scripts leading to inaccurate fills, according to MarketWatch; and decreased administrative efficiencies. By enabling care providers to send accurate, easy-to-read prescriptions directly from the point-of-care, patients realize significant short- and long-term benefits.
One of these benefits is greater adherence. According to a study in JAMA Dermatology, e-prescribing is associated with a significant decrease in primary nonadherence among patients. In addition, e-prescribing helps improve patient-provider dialogue, reduces costs through a wider selection of formulary and generic alternatives, and gives providers immediate access to a patient’s formulary, drug history, and prescription benefits for decision support – increasing accuracy, efficiency, and safety across the board.
Accuracy
A major opportunity for improvement is reducing prescription errors, and e-prescribing has proven to reduce the likelihood. When using hard copy scripts, the barrier of interpretation can contribute to inaccurate fills. This occurs when a pharmacist incorrectly interprets the physician's handwriting and inadvertently supplies the patient with the wrong drug, dose or quantity, which can adversely impact a patient’s health.
Related article: How 2018 Pharmacy Trends Are Affecting 2019
A digitally received script removes the need for interpretation and drives a higher level of clinical accuracy and integrity. Studies have shown that error rates have decreased from 42.5 per 100 prescriptions to 6.6 per 100 prescriptions (nearly a seventh of the previous level) in just one year after the adoption of e-prescribing.
Efficiency
With current e-prescribing systems, providers receive eligibility, formulary, and medication history in real time, providing visibility to lower-cost alternatives that can enhance overall cost effectiveness for patients.
As an added convenience, prescriptions can also be automatically sent to the patient’s pharmacy of choice. This eliminates the need for patients to physically bring a prescription to the pharmacy, drop it off, leave, and come back to pick up their medication. This also saves patients time, which can translate into dollars for people who don’t have to take time away from work to manage their prescriptions.
Safety
Finally, the positive impact of e-prescribing on patient safety cannot be understated. In addition to reducing the risk of an inaccurately dispensed drug or dose, e-prescribing gives physicians access to a patient’s prescription drug history at the point of prescribing. When physicians have access to this information, they can appropriately prescribe dose increases or add another concomitant medication to ensure positive therapeutic outcomes are achieved (e.g., blood pressure; HbA1c; cholesterol levels).
E-prescribing can also play an important role in managing controlled medications, such as opioids. Access to a patient’s prescription drug history can help mitigate fraud and plays an important role in addressing our nationwide crisis of drug overdose and death. Legislation has been introduced in the Senate that would require healthcare providers to employ e-prescribing for all opioids and other controlled substances for Medicare Part D recipients beginning in 2021, according to Point of Care Partners (healthcare management consultants in Jacksonville, Florida). Several states already have similar legislation in place for all controlled prescribing, and others have legislation pending. E-prescribing, especially when combined with other healthcare services such as home delivery, results in better accuracy, reduction in error, and the prevention of abuse, fraud, or manipulation.
Looking ahead
As adoption rates rise and the industry progresses toward mandated e-prescribing, physicians will be required to use the initial e-prescribing interface. This will further increase the quality and cost-efficiency of care for patients and minimize administrative burden for the provider and patient.
This transition has accelerated development of more comprehensive digital tools, including OptumRx’s PreCheck MyScript, which enhances the e-prescribing process by providing real-time, patient-specific benefit information at the point-of-care. As a result, members can see improved health outcomes, improved access to therapy, and significantly lower out-of-pocket costs.
Related article: Four Reasons Payers Are Investing in Real-Time Benefit Check
With progress toward the universal adoption of e-prescribing, our nation’s pharmacy care landscape will see increased efficiency of the prescribing process and lowering of incurred costs for all involved. From clients and members to physicians and pharmacies, e-prescribing promises better coordination of care and communication across the healthcare continuum.
David Calabrese, RPh, MHP, is senior vice president and chief pharmacy officer of OptumRx. He also is an editorial advisor for Managed Healthcare Executive.
In the Scope of Virtual Health and the Future of “Website” Manner, Per Ateev Mehrotra
August 10th 2023Briana Contreras, an editor of Managed Healthcare Executive, had the pleasure of catching up with MHE Editorial Advisory Board Member, Ateev Mehrotra, MD, MPH, who is a professor of healthcare policy at Harvard Medical School and an Associate Professor of Medicine and Hospitalist at Beth Israel Deaconess Medical Center.
Listen
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen